Search results
Results from the WOW.Com Content Network
[16] [17] TALEN and CRISPR are the two most commonly used and each has its own advantages. [18] TALENs have greater target specificity, while CRISPR is easier to design and more efficient. [18] The development of the CRISPR-Cas9 gene editing system has effectively halved the amount of time needed to develop genetically modified animals. [19
The development of CRISPR technology has been highly influential in the field of plant biotechnology, and has the potential to revolutionize the future of agriculture. [ 211 ] CRISPR-Cas systems are most commonly introduced into plants by Agrobacterium -mediated transformation, although particle bombardment and protoplast transformation are ...
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
(Reuters) -Twenty-four companies are working to develop an avian flu vaccine for cattle, as the virus spreads among U.S. dairy herds, Agriculture Secretary Tom Vilsack told Reuters on Wednesday ...
The company has previously developed vaccines for avian flu, including one used by the US Fish and Wildlife Service to protect California condors in 2023, Zoetis said, noting, “The decision to ...
A New Jersey pharmaceutical company has received a "conditional license" for its bird flu vaccine for use in chickens. The vaccine, developed by Zoetis, targets the H5N2 subtype of avian influenza ...
Agricultural biotechnology, also known as agritech, is an area of agricultural science involving the use of scientific tools and techniques, including genetic engineering, molecular markers, molecular diagnostics, vaccines, and tissue culture, to modify living organisms: plants, animals, and microorganisms. [1]
CRISPR Therapeutics is applying this technology platform to research, develop and commercialize medicines for various diseases including sickle cell disease, beta thalassemia, various cancers, type 1 diabetes, and cardiovascular diseases. [7] The CEO is Samarth Kulkarni, PhD, who joined the company in 2015 as chief business officer.